Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re...ttccrr

Aug 17, 2007 01:09PM

Aug 17, 2007 01:21PM

Aug 17, 2007 01:49PM
I didn't say Swartz wanted to reduce their risk by selling, I simply look at the decreasing numbers of warrants and shares and try to find an explanation for this, nothing more.

And I don't think the dividends will continue - I guess, they've been the sweeties for Swartz to accept a new Patriot without Swartz.

But as I said, just IMHO, and we might see new numbers in the next proxy. If S&L are still in the list as beneficial owner I stand corrected.

GLTA

Aug 18, 2007 01:32PM

Aug 18, 2007 03:29PM
Share
New Message
Please login to post a reply